Levothyroxine Sodium Tablet
Product Images NDC 51655-846

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Levothyroxine Sodium (NDC 51655-846). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

51655-846-52 (51655 846 52 Rev A 03 23)

51655-846-52 (51655 846 52 Rev A 03 23)
NDC: 51655-846-52 R O Levothyroxine Sodium Tablets, USP 25 mcg (0.025 mg) 30 Tablets Rx Only. Dosage instructions are available in the package insert. The tablets should be stored at 25°C (77°F); temperatures between 15°-30°C (59°-86°F) are allowed (as per USP Controlled Room Temperature regulations). Keep out of the reach of children, store in the original container, and protect from light and moisture. The product was repackaged by Northwind Pharmaceuticals, sourced from LOT 0000000000 of Lannett Company, Inc. The product was repackaged from 0527-3280-XX, and the GTIN is 00351655846520. The serial number is 000000000000000. The expiry date is 00/00/0000, and the assigned LOT is 0000000000.*
FDA Label Image

Levothyroixe Molecule (Levothyroxine Molecule)

Levothyroixe Molecule (Levothyroxine Molecule)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.